Eintrag weiter verarbeiten
Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
Gespeichert in:
Zeitschriftentitel: | Journal of Clinical Oncology |
---|---|
Personen und Körperschaften: | , , , , , , , , , , , , , , , , , , |
In: | Journal of Clinical Oncology, 32, 2014, 15_suppl, S. 9031-9031 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
American Society of Clinical Oncology (ASCO)
|
Schlagwörter: |
author_facet |
Zimmer, Lisa Eigentler, Thomas K. Vaubel, Julia-Marianne Mohr, Peter Jradi, Zeinab Kiecker, Felix Utikal, Jochen Berking, Carola Kämpgen, Eckhart Hauschild, Axel Dippel, Edgar Rompel, Rainer Fluck, Michael Stadler, Rudolf Herbst, Rudolf Terheyden, Patrick Garbe, Claus Loquai, Carmen Schadendorf, Dirk Zimmer, Lisa Eigentler, Thomas K. Vaubel, Julia-Marianne Mohr, Peter Jradi, Zeinab Kiecker, Felix Utikal, Jochen Berking, Carola Kämpgen, Eckhart Hauschild, Axel Dippel, Edgar Rompel, Rainer Fluck, Michael Stadler, Rudolf Herbst, Rudolf Terheyden, Patrick Garbe, Claus Loquai, Carmen Schadendorf, Dirk |
---|---|
author |
Zimmer, Lisa Eigentler, Thomas K. Vaubel, Julia-Marianne Mohr, Peter Jradi, Zeinab Kiecker, Felix Utikal, Jochen Berking, Carola Kämpgen, Eckhart Hauschild, Axel Dippel, Edgar Rompel, Rainer Fluck, Michael Stadler, Rudolf Herbst, Rudolf Terheyden, Patrick Garbe, Claus Loquai, Carmen Schadendorf, Dirk |
spellingShingle |
Zimmer, Lisa Eigentler, Thomas K. Vaubel, Julia-Marianne Mohr, Peter Jradi, Zeinab Kiecker, Felix Utikal, Jochen Berking, Carola Kämpgen, Eckhart Hauschild, Axel Dippel, Edgar Rompel, Rainer Fluck, Michael Stadler, Rudolf Herbst, Rudolf Terheyden, Patrick Garbe, Claus Loquai, Carmen Schadendorf, Dirk Journal of Clinical Oncology Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups. Cancer Research Oncology |
author_sort |
zimmer, lisa |
spelling |
Zimmer, Lisa Eigentler, Thomas K. Vaubel, Julia-Marianne Mohr, Peter Jradi, Zeinab Kiecker, Felix Utikal, Jochen Berking, Carola Kämpgen, Eckhart Hauschild, Axel Dippel, Edgar Rompel, Rainer Fluck, Michael Stadler, Rudolf Herbst, Rudolf Terheyden, Patrick Garbe, Claus Loquai, Carmen Schadendorf, Dirk 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2014.32.15_suppl.9031 Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups. Journal of Clinical Oncology |
doi_str_mv |
10.1200/jco.2014.32.15_suppl.9031 |
facet_avail |
Online Free |
finc_class_facet |
Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNC4zMi4xNV9zdXBwbC45MDMx |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNC4zMi4xNV9zdXBwbC45MDMx |
institution |
DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 |
imprint |
American Society of Clinical Oncology (ASCO), 2014 |
imprint_str_mv |
American Society of Clinical Oncology (ASCO), 2014 |
issn |
0732-183X 1527-7755 |
issn_str_mv |
0732-183X 1527-7755 |
language |
English |
mega_collection |
American Society of Clinical Oncology (ASCO) (CrossRef) |
match_str |
zimmer2014openlabelmulticentersinglearmphaseiistudydecogtrialtofurtherevaluatetheefficacyandsafetyofipilimumabinpatientswithcutaneousmelanomaandraresubgroups |
publishDateSort |
2014 |
publisher |
American Society of Clinical Oncology (ASCO) |
recordtype |
ai |
record_format |
ai |
series |
Journal of Clinical Oncology |
source_id |
49 |
title |
Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups. |
title_unstemmed |
Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups. |
title_full |
Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups. |
title_fullStr |
Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups. |
title_full_unstemmed |
Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups. |
title_short |
Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups. |
title_sort |
open-label, multicenter, single-arm phase ii study (decog-trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups. |
topic |
Cancer Research Oncology |
url |
http://dx.doi.org/10.1200/jco.2014.32.15_suppl.9031 |
publishDate |
2014 |
physical |
9031-9031 |
description |
|
container_issue |
15_suppl |
container_start_page |
9031 |
container_title |
Journal of Clinical Oncology |
container_volume |
32 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792320472386371588 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T10:46:40.651Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Open-label%2C+multicenter%2C+single-arm+phase+II+study+%28DeCOG-Trial%29+to+further+evaluate+the+efficacy+and+safety+of+ipilimumab+in+patients+with+cutaneous+melanoma+and+rare+subgroups.&rft.date=2014-05-20&genre=article&issn=1527-7755&volume=32&issue=15_suppl&spage=9031&epage=9031&pages=9031-9031&jtitle=Journal+of+Clinical+Oncology&atitle=Open-label%2C+multicenter%2C+single-arm+phase+II+study+%28DeCOG-Trial%29+to+further+evaluate+the+efficacy+and+safety+of+ipilimumab+in+patients+with+cutaneous+melanoma+and+rare+subgroups.&aulast=Schadendorf&aufirst=Dirk&rft_id=info%3Adoi%2F10.1200%2Fjco.2014.32.15_suppl.9031&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792320472386371588 |
author | Zimmer, Lisa, Eigentler, Thomas K., Vaubel, Julia-Marianne, Mohr, Peter, Jradi, Zeinab, Kiecker, Felix, Utikal, Jochen, Berking, Carola, Kämpgen, Eckhart, Hauschild, Axel, Dippel, Edgar, Rompel, Rainer, Fluck, Michael, Stadler, Rudolf, Herbst, Rudolf, Terheyden, Patrick, Garbe, Claus, Loquai, Carmen, Schadendorf, Dirk |
author_facet | Zimmer, Lisa, Eigentler, Thomas K., Vaubel, Julia-Marianne, Mohr, Peter, Jradi, Zeinab, Kiecker, Felix, Utikal, Jochen, Berking, Carola, Kämpgen, Eckhart, Hauschild, Axel, Dippel, Edgar, Rompel, Rainer, Fluck, Michael, Stadler, Rudolf, Herbst, Rudolf, Terheyden, Patrick, Garbe, Claus, Loquai, Carmen, Schadendorf, Dirk, Zimmer, Lisa, Eigentler, Thomas K., Vaubel, Julia-Marianne, Mohr, Peter, Jradi, Zeinab, Kiecker, Felix, Utikal, Jochen, Berking, Carola, Kämpgen, Eckhart, Hauschild, Axel, Dippel, Edgar, Rompel, Rainer, Fluck, Michael, Stadler, Rudolf, Herbst, Rudolf, Terheyden, Patrick, Garbe, Claus, Loquai, Carmen, Schadendorf, Dirk |
author_sort | zimmer, lisa |
container_issue | 15_suppl |
container_start_page | 9031 |
container_title | Journal of Clinical Oncology |
container_volume | 32 |
description | |
doi_str_mv | 10.1200/jco.2014.32.15_suppl.9031 |
facet_avail | Online, Free |
finc_class_facet | Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNC4zMi4xNV9zdXBwbC45MDMx |
imprint | American Society of Clinical Oncology (ASCO), 2014 |
imprint_str_mv | American Society of Clinical Oncology (ASCO), 2014 |
institution | DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1 |
issn | 0732-183X, 1527-7755 |
issn_str_mv | 0732-183X, 1527-7755 |
language | English |
last_indexed | 2024-03-01T10:46:40.651Z |
match_str | zimmer2014openlabelmulticentersinglearmphaseiistudydecogtrialtofurtherevaluatetheefficacyandsafetyofipilimumabinpatientswithcutaneousmelanomaandraresubgroups |
mega_collection | American Society of Clinical Oncology (ASCO) (CrossRef) |
physical | 9031-9031 |
publishDate | 2014 |
publishDateSort | 2014 |
publisher | American Society of Clinical Oncology (ASCO) |
record_format | ai |
recordtype | ai |
series | Journal of Clinical Oncology |
source_id | 49 |
spelling | Zimmer, Lisa Eigentler, Thomas K. Vaubel, Julia-Marianne Mohr, Peter Jradi, Zeinab Kiecker, Felix Utikal, Jochen Berking, Carola Kämpgen, Eckhart Hauschild, Axel Dippel, Edgar Rompel, Rainer Fluck, Michael Stadler, Rudolf Herbst, Rudolf Terheyden, Patrick Garbe, Claus Loquai, Carmen Schadendorf, Dirk 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2014.32.15_suppl.9031 Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups. Journal of Clinical Oncology |
spellingShingle | Zimmer, Lisa, Eigentler, Thomas K., Vaubel, Julia-Marianne, Mohr, Peter, Jradi, Zeinab, Kiecker, Felix, Utikal, Jochen, Berking, Carola, Kämpgen, Eckhart, Hauschild, Axel, Dippel, Edgar, Rompel, Rainer, Fluck, Michael, Stadler, Rudolf, Herbst, Rudolf, Terheyden, Patrick, Garbe, Claus, Loquai, Carmen, Schadendorf, Dirk, Journal of Clinical Oncology, Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups., Cancer Research, Oncology |
title | Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups. |
title_full | Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups. |
title_fullStr | Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups. |
title_full_unstemmed | Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups. |
title_short | Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups. |
title_sort | open-label, multicenter, single-arm phase ii study (decog-trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups. |
title_unstemmed | Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups. |
topic | Cancer Research, Oncology |
url | http://dx.doi.org/10.1200/jco.2014.32.15_suppl.9031 |